Dr. Karumanchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Boulevard
Los Angeles, CA 90048Phone+1 310-423-7608Fax+1 310-423-0225
Education & Training
Kilpauk Medical CollegeClass of 1992
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine
Certifications & Licensure
CA State Medical License 2017 - 2025
MA State Medical License 1996 - 2025
Clinical Trials
- Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children Start of enrollment: 2015 May 03
Roles: Contact
Publications & Presentations
PubMed
- 3 citationsGlycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.Mengyao Tang, Anders H Berg, Hui Zheng, Eugene P Rhee, Andrew S Allegretti
American Journal of Kidney Diseases. 2024-09-01 - 3 citationsPlacental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes.Marie-France Hivert, Frédérique White, Catherine Allard, Kaitlyn James, Sana Majid
Nature Medicine. 2024-06-01 - 1 citationsHigh-throughput mRNA-seq atlas of human placenta shows vast transcriptome remodeling from first to third trimester†.Tania L Gonzalez, Sahar Wertheimer, Amy E Flowers, Yizhou Wang, Chintda Santiskulvong
Biology of Reproduction. 2024-05-09
Press Mentions
Cedars-Sinai to Lead International Study on How the Placenta Affects Heart HealthNovember 21st, 2024
Voice of AmericaJune 30th, 2024- November Research HighlightsNovember 30th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
